La aprobación de CoronaVac en Brasil y Chile: algunas lecciones sobre los retos regulatorios de vacunas
Este análisis compara y sistematiza algunos hitos de la aprobación en Brasil y Chile de la vacuna CoronaVac del laboratorio chino Sinovac, desde diciembre 2020 hasta octubre 2021, respecto de cómo se fundamentó su eficacia e inmunogenicidad. A tal fin se realizó un análisis exhaustivo de la do...
Saved in:
Main Author: | Ana Sojo (Author) |
---|---|
Format: | Book |
Published: |
Pan American Health Organization,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ANCA-associated vasculitis following the CoronaVac vaccination
by: Yaohui Ma, et al.
Published: (2022) -
Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers
by: Gulsum Iclal Bayhan, et al.
Published: (2022) -
Adverse events associated with CoronaVac in a university hospital
by: Lana N. SILVA-SANTOS, et al.
Published: (2022) -
Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers
by: Hazal Cansu Çulpan, et al.
Published: (2023) -
Risk of adverse events following CoronaVac's COVID-19 vaccination in women with and without autoimmunity
by: Stevent Sumantri, et al.
Published: (2023)